Publications

5674 Results

Comparison of quality of life (QLI) outcomes for two chemotherapy regimens in non-small cell lung cancer (NSCLC).

Authors
CM Moinpour;B Lyons;LC Lovato;PK Grevstad;K Kelly;J Crowley;D Gandara
Journal / Conference
Lung Cancer 29(Suppl.2):34(#109)
Year
2000
Research Committee(s)
Lung

Response to chemotherapy as a predictor of survival in advanced non-small cell lung cancer (NSCLC): review of the Southwest Oncology Group (SWOG) database.

Authors
W Akerley;J Crowley;D Giroux;D Gandara
Journal / Conference
Lung Cancer 29(Suppl.2):33(#106)
Year
2000
Research Committee(s)
Lung

Pathologic stage IIIb non-small cell lung cancer (NSCLC): prolonged survival with consolidation docetaxel following concurrent chemoradiotherapy (SWOG 9504).

Authors
DR Gandara;LC Lovato;KS Albain;B Leigh;PN Lara;JJ Crowley;RB Livingston
Journal / Conference
Lung Cancer 29(Suppl.2):92(#302)
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-9504

An economic analysis alongside a prospective randomized multicenter clinical trial of cisplatin/vinorelbine vs. carboplatin/paclitaxel for advanced non small cell lung cancer.

Authors
SD Ramsey;CM Moinpour;LC Lovato;PK Grevstad;C Presant;DR Gandara;K Kelly
Journal / Conference
Lung Cancer 29(Suppl.2):4(#5)
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-9509

A phase II study of cisplatin, etoposide, and paclitaxel (PET) with G-CSF in untreated patients with extensive small cell lung cancer: a Southwest Oncology Group trial.

Authors
K Kelly;PA Bunn;L Lovato;J Crowley;RB Livingston;DR Gandara
Journal / Conference
Lung Cancer 29(Suppl.2):8(#20)
Year
2000
Research Committee(s)
Lung
Study Number(s)
S9705

Letter to the editor: Observational studies and randomzied trials

Authors
PY Liu;G Anderson;JJ Crowley
Journal / Conference
New England Journal of Medicine 343(16):1195
Year
2000

Phase II clinical trial design for noncytotoxic anticancer agents for which time to disease progression is the primary endpoint

Authors
R Mick;JJ Crowley;RJ Carroll
Journal / Conference
Controlled Clinical Trials 21:343-359
Year
2000
Research Committee(s)
Breast
Study Number(s)
SWOG-8312

Current status of therapy for advanced non-small cell lung cancer: a perspective from the Southwest Oncology Group (SWOG)

Authors
DR Gandara;K Kelly;P Gumerlock;J Crowley
Journal / Conference
Lung Cancer 29(Suppl.2):186
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-9509

Gemcitabine and platinum combinations in advanced non-small cell lung cancer: an update

Authors
DR Gandara;MJ Edelman;P Lara;D Lau
Journal / Conference
Lung Cancer 29(Suppl.2):7
Year
2000
Research Committee(s)
Lung
Study Number(s)
S9718

A simple classification of gastric cancer

Authors
OJ Kim;G Stemmermann;A Noffsinger;C Fenoglio-Preiser
Journal / Conference
Modern Pathology 13(1):83a(#474)
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)